Prelude Therapeutics Incorporat

Q2 2024 13F Holders

Symbol
PRLD
CUSIP
74065P101
Type
Equity
Class
COM
Num filings
66
Total reported value, excl. options
$130 M
Manager Report Date Value ($000) Shares Option Type